Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04849806 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sympathetic Nerve Activity Predictors in Patients With Chronic Obstructive Pulmonary Disease

Study acronym: SNAP-COPD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment target: 80 to 135
    • Primary completion date: Apr 2024 to Dec 2028
    • Study completion date: Aug 2024 to Dec 2028
    • Collaborators expanded, about 8 words
    v8
  2. Notable Primary completion date: Aug 2023 to Apr 2024v7
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v6
  4. Notable Primary completion date: Aug 2022 to Aug 2023
    • Start date: Aug 2021 to May 10, 2022
    • Study completion date: Aug 2023 to Aug 2024
    v5
  5. Minor 2 versions Re-verified since Apr 27, 2021, no change to tracked fieldsv3-v4
  6. Minor Study title expanded, about 1 wordv2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
1,119 trials monitored
See 34 trials at risk
The project will be pursued in our respiratory, autonomic nervous system physiology laboratory (Respiratory, autonomic nervous system physiology laboratory, Department of Pneumology and Intensive Care Medicine, RWTH Aachen University Hospital; Head of Department: Professor Michael Dreher). Overactivity of the sympathetic nerve activity (SNA) axis with "centrally" increased heart rate and peripheral vasoconstriction is a known phenomenon in patients with systolic heart failure (HF) and has recently been described in patients with primary lung disease as seen in chronic obstructive pulmonary disease (COPD). However, systematic analyses on this clinically relevant topic are currently lacking. Thus, using a comprehensive, multimodal approach and state-of-the-art technology, this research project is designed to determine the extent and nature of increased SNA in COPD (AIM 1) and evaluate the underlying mechanisms (AIM 2). The project will address the following hypotheses: 1. In COPD, concomitant obstructive sleep apnea is independently associated with increased SNA. 2. Precapillary pulmonary hypertension (PH), inspiratory muscle dysfunction and systemic inflammation describe a COPD phenotype characterised by increased SNA with a different subtype.
Trial Details
NCT Number NCT04849806
Lead Sponsor RWTH Aachen University
Collaborators: DFG - Deutsche Forschungs Gemeinschaft (German Research Foundation)
Conditions
(from sponsor)
COPD, Sympathetic Nervous System Diseases, Catecholamine; Overproduction
Related terms Autonomic Nervous System Diseases, Pulmonary Disease, Chronic Obstructive
Enrollment 135 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov